Methylprednisolone Completed Phase 3 Trials for Respiratory Distress Syndrome, Adult / Chronic Lung Diseases Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00000579Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)